Navigation Links
ConvaTec Announces the Appointment of Ken Berger to the Position of CEO Effective March 6, 2012
Date:2/21/2012

SKILLMAN, N.J., Feb. 21, 2012 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announces that Ken Berger will assume the position of CEO, ConvaTec, and will be appointed to the ConvaTec Board of Directors.

Berger joins ConvaTec from Thermo Fisher Scientific where he spent the last ten years, most recently as Senior Vice President and Group President of the Specialty Diagnostics Group, a global $2 billion high-value diagnostics business.  "We are excited to have Ken take over the helm of ConvaTec," said Toni Weitzberg, Chairman of the Board of Directors for ConvaTec.  "His track record of building highly profitable businesses, combined with diverse global experience and a history of building strong leadership teams is well suited to take ConvaTec to the next level of performance excellence."

"I am pleased to work with Nordic Capital and Avista Capital Partners as CEO of ConvaTec," said Berger, "and I look forward to working with the ConvaTec team to realize the incredible potential of this business."

This appointment follows the mutual agreement between David I. Johnson and the ConvaTec Board of Directors that he will step down as CEO, effective March 5, 2012.  "Dave successfully managed the carve-out from Bristol Myers Squibb Co. and created an independent global company with a strong platform for growth," stated Weitzberg. "The Board thanks him for his service in leading ConvaTec over the past six years, and for his dedication to the Company for over twelve years."

"I am proud to leave this fine organization with a strengthened financial foundation, renewed growth momentum; and of course, a continued commitment to the company mission," said Johnson.  "I am confident that the entire organization is ready to take ConvaTec to even greater heights."

Over the next sixty days, Johnson will work with the Board and his successor to ensure an orderly transition of leadership.

About ConvaTecConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics, Continence and Critical Care, and Infusion Devices – ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit www.convatec.com.Contacts: Media Relations: Investor Relations:Nimisha Savani Tim WinstonVP, Corporate Affairs VP, TreasurerConvaTec

ConvaTec908-904-2522

908-904-2988mediarelations@convatec.com  

investorrelations@convatec.com


'/>"/>

SOURCE ConvaTec
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ConvaTec Healthcare Announces 2011 Third Quarter Earnings Call
2. ConvaTec Announces Acquisition of Farnhurst Medical
3. ConvaTec Announces Acquisition of Boston Medical Device
4. ConvaTec Healthcare Announces 2011 Second Quarter Earnings Call
5. ConvaTec Announces Asia-Pacific Leadership Appointments
6. Preliminary Results of a Large Scale Study Show ConvaTec Moldable Technology™ Skin Barriers Help to Prevent and Improve Peristomal Skin Issues in Ostomy Patients
7. ConvaTec Healthcare Announces 2011 First Quarter Earnings Call
8. ConvaTec Presents New Data on ConvaTec Moldable Technology™ and Vitala™ Continence Control Device in Ostomy Care
9. ConvaTec Announces Acquisition of Trent Direct
10. ConvaTec Healthcare Announces 2010 Year-End Earnings Call
11. ConvaTec Supported Studies to be Presented at the 24th Annual Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... 13, 2017 It should come as no surprise ... is in the midst of a crippling opioid epidemic. According ... the number of overdose deaths from opiate-based medications has quadrupled, ... a million dead from 2001 to 2015". During this time, ... has similarly quadrupled, drawing a compelling link between prescription and ...
(Date:7/13/2017)... 2017 RK Logistics Group, Inc. was awarded ... its Fremont, CA headquarters facility where ... and San Jose for hi-tech, pharmaceutical ... , with its Fremont Innovation District, is excited to ... powerful resource to the hundreds of biotech, pharma and biomed ...
(Date:7/12/2017)... -- CarpalAID is a revolutionary new product that relieves painful carpal ... tunnel syndrome affects more than 8 million people a year. Women ... The common methods of treating CTS are painful surgery, the use ... gloves. ... CarpalAID is a clear patch worn on the palm of the ...
Breaking Medicine Technology:
(Date:7/23/2017)... ... 23, 2017 , ... Better education to coaches and parents ... work today at the American Orthopaedic Society for Sports Medicine’ s ... to prospectively document the association between sports specialization and lower extremity injuries in ...
(Date:7/23/2017)... ... July 23, 2017 , ... “Squiggy’s Outdoor Adventure”: a turtle’s backyard ... the creation of published author, Paula Christian, a wife and mother to three amazing, ... family, who center their lives on God. She loves to tell stories to ...
(Date:7/21/2017)... ... , ... "As a doctor of lung medicine managing chest diseases for more ... said an inventor from Center Valley, Pa. "My idea is to improve the device ... the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient means of draining pleural ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Karen Miller Agency, a ... in the greater Birmingham area, is joining the Chris Hammond Youth Foundation in ... the region. , The Chris Hammond Youth Foundation maintains athletic facilities in rural ...
(Date:7/21/2017)... ... July 21, 2017 , ... Bernard R. Bach, Jr., MD, orthopaedic surgeon at ... Orthopaedic Society of Sports Medicine (AOSSM) , received the 2017 Robert E. Leach Sports ... Toronto, Canada. This prestigious award is given annually to honor those who have made ...
Breaking Medicine News(10 mins):